Keeping Current

A molecular clock is ticking in your patients with metastatic breast cancer. Are you listening? Credit available for this activity expires: 10/12/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/frontiers-modern-oncology-molecular-guided-strategies-hr-2026a10010phecd=bdc_podcast_libsyn_mscpedu

Discover how novel therapies and expert consensus on the KDIGO framework are revolutionizing IgAN management to slow disease progression. Credit available for this activity expires: 10/13/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/navigating-iga-nephropathy-management-evolving-treatment-2026a10010le?ecd=bdc_podcast_libsyn_mscpedu

ADCs are moving from the metastatic setting into curative-intent neoadjuvant and adjuvant lines of treatment. Are you ready? Credit available for this activity expires: 10/5/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/antibody-drug-conjugate-therapy-early-breast-cancer-2026a10010lp?ecd=bdc_podcast_libsyn_mscpedu

Do you know who to test, when to test, and which biomarker test to use? Credit available for this activity expires: 9/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/solving-alzheimers-disease-biomarker-puzzle-live-european-2026a1000y9g?ecd=bdc_podcast_libsyn_mscpedu

Do you know how to meet the challenges of treating uveitic macular edema? Credit available for this activity expires: 9/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/advancing-uveitic-macular-edema-management-whats-new-2026a1000y92?ecd=bdc_podcast_libsyn_mscpedu

Move beyond supportive care with targeted therapies for immunoglobulin A nephropathy (IgAN) management. Credit available for this activity expires: 09/24/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/patient-journeys-iga-nephropathy-optimizing-outcomes-patient-2026a1000xq5?ecd=bdc_podcast_libsyn_mscpedu

How can adjuvant therapy be optimally individualized? What tools and insights are required? Join us to learn more. Credit available for this activity expires: 09/21/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/refining-adjuvant-therapy-hr-positive-her2-negative-early-2026a1000ysl?ecd=bdc_podcast_libsyn_mscpedu

Can CAR T-cell therapies achieve drug-free remission in severe refractory autoimmune diseases? Credit available for this activity expires: 9/22/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/patient-journey-severe-refractory-autoimmune-rheumatic-2026a1000xbu?ecd=bdc_podcast_libsyn_mscpedu

Are you up to speed on the latest updates on molecular-guided therapies in HR-positive/HER2-negative metastatic breast cancer (MBC)? Join us to learn more. Credit available for this activity expires: 9/18/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/translating-molecular-insights-practice-hr-positive-her2-2026a1000y0g?ecd=bdc_podcast_libsyn_mscpedu

Discover how emerging targeted therapies address systemic drivers in MASLD and MASH. Credit available for this activity expires: 9/8/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/targeting-metabolic-driver-forward-looking-approach-obesity-2026a1000t0l?ecd=bdc_podcast_libsyn_mscpedu

Fatigue, unpredictability, and life goals; integrate what patients say they need into how you treat myasthenia gravis (MG). Credit available for this activity expires: 9/4/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/whole-patient-integrating-lived-experience-myasthenia-gravis-2026a1000rf7?ecd=bdc_podcast_libsyn_mscpedu

Are your epilepsy patients achieving true seizure freedom, or is it time to adjust their therapy? Credit available for this activity expires: 9/1/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/epilepsy-general-neurology-practice-optimizing-therapeutic-2026a1000rgh?ecd=bdc_podcast_libsyn_mscpedu

Compare global myasthenia gravis (MG) guidelines to optimize local, patient-centered treatment pathways. Credit available for this activity expires: 8/17/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/myasthenia-gravis-guidelines-global-view-local-practice-2026a1000q15?ecd=bdc_podcast_libsyn_mscpedu

Are non-factor therapies enough to protect your hemophilia A patients during surgery? Credit available for this activity expires: 8/18/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/mechanism-management-applying-evidence-hemophilia-clinic-2026a1000p5z?ecd=bdc_podcast_libsyn_mscpedu

Master multimodality imaging and autonomic red flag screening in your transthyretin amyloid cardiomyopathy (ATTR-CM) practice. Episode learning points & Disclosures: https://www.medscape.org/viewarticle/updating-our-checklist-transthyretin-amyloid-cardiomyopathy-2026a1000pul?ecd=bdc_podcast_libsyn_mscpedu

What tests are best to assess early cognitive symptoms? Credit available for this activity expires: 03/05/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003254?ecd=bdc_podcast_libsyn_mscpedu

Explore emerging B-cell-targeted therapies for immunoglobulin A nephropathy (IgAN). Unpack novel mechanisms of action (MOAs) and the latest clinical data to protect kidneys now. Credit available for this activity expires: 8/5/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/why-target-april-iga-nephropathy-management-get-speed-2026a1000ooh?ecd=bdc_podcast_li...

Are you up to date on developments in technology for treating retinovascular disease? Credit available for this activity expires: 7/24/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/beyond-intervals-next-era-continuous-delivery-retinal-2026a1000mm4?ecd=bdc_podcast_libsyn_mscpedu

Gain expert insights on how best to implement GDMT for your patients in the transition from hospitalization to post-discharge. Credit available for this activity expires: 7/22/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/when-and-how-should-i-optimize-heart-failure-treatments-my-2026a1000ngg?ecd=bdc_podcast_libsyn_mscpedu

Update PFIC care, from genetic diagnosis to guideline-recommended management. Credit available for this activity expires: 7/21/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/evolving-diagnostic-and-management-landscape-progressive-2026a1000mlz?ecd=bdc_podcast_libsyn_mscpedu

Master the latest evidence-based meds and dual therapies to help your patients quit for good. Credit available for this activity expires: 06/25/2027 Earn Credit / Learning Objectives & Disclosures:  https://www.staging.medscape.org/viewarticle/pharmacological-and-combination-interventions-nicotine-2026a1000ldi?ecd=bdc_podcast_libsyn_mscpedu

Is sustained hemostatic normalization achievable across all hemophilia A patients? Examine the evidence behind today's therapeutic advances. Credit available for this activity expires: 6/26/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/normalizing-hemostasis-achievable-goal-hemophilia-2026a1000jxv?ecd=bdc_podcast_libsyn_mscpedu

Drs García-Pavia and Sperry break down the top 5 mistakes in transthyretin amyloid cardiomyopathy (ATTR-CM) management and share clinical solutions for earlier, optimized patient care. Credit available for this activity expires: 6/25/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/top-5-errors-transthyretin-amyloid-cardiomyopathy-management-2026a1000jpe?ecd...

Learn to optimize durability and drying with new second-generation anti-VEGF therapies. Credit available for this activity expires: 6/19/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/https://www.medscape.org/viewarticle/better-drying-longer-lasting-second-generation-anti-vegf-2026a1000k53?ecd=bdc_podcast_libsyn_mscpedu

Do you know how tumor-agnostic therapies are helping to reshape cancer treatment pathways? Credit available for this activity expires: 6/16/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/shaping-future-precision-oncology-biomarker-driven-care-2026a1000jpk?ecd=bdc_podcast_libsyn_mscpedu